The 2000 Mile Rule

When I was a kid, my Dad and I drove across the Nullarbor Plain, from Adelaide to Perth. I will never forget the experience and it rests in my mind as one of the most visually spectacular stretches of road I have ever driven along. It also very much reinforced my perception of how remote and far-flung…

Sydney narrowly escapes further public nakedness…

I think it is fair to say that comparing the visual thrill of a Spencer Tunick installation (feature image) to the mental vision of Yours Truly standing at the York St. entrance of Sydney’s Wynyard Train Station in his “birthday suit” is a bit of a stretch but hey, you have to work with what you have. I…

The Australian Schultz Exchange

To be honest with you, I am not a big fan of over-regulation, I like things simple and I hate “Big Government”. But I also believe that something as important as our public markets need some boundary conditions. In my mind, the ASX has demonstrated in the past few weeks that it is not only…

BLT : Pure Theatre

Back on the 3rd of July, Benitec (ASX : BLT) filed a regulatory notice in relation to a change of interest for a substantial holder, namely RA Capital (and related party). No big deal, not a big problem really. Normally in the lead-up to an IPO, there would be no drama in watching a large investor…

Good MAAAAAAWNIN’ Sydney!

Good maaaaaawning¬†Stuart Roberts in Sydney, Let me start this email by asking you, Prima BioMed, a question. Are you optimistic about the state of the world at the moment, or pessimistic? Me, I’m pessimistic, indeed, I’ve been particularly pessimistic ever since I watched your stock rally on the basis of yesterday’s sensationalist drivel. I couldn’t…

NRT, ANP, PYC, ACL, OBJ : A Week in Contrast

Last week was a pretty exciting week in Australian life sciences. Quite a bit happened, in fact I struggled to stay on top of it while being on vacation. We’ve seen a couple of good things happen, like PharmAxis, Sirtex recovery, etc. that are real bright spots on the Aussie biotech landscape. We’ve seen some…